SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Vasiliou V, Pappa A, Estey T. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab Rev 2004; 36: 279299.
  • 2
    Cai J, Weiss ML, Rao MS. In search of “stemness”. Exp Hematol 2004; 32: 585598.
  • 3
    Douville J, Beaulieu R, Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 2008; 23: 23.
  • 4
    Armstrong L, Stojkovic M, Dimmick I et al. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 2004; 22: 11421151.
  • 5
    Corti S, Locatelli F, Papadimitriou D et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006; 24: 975985.
  • 6
    Fallon P, Gentry T, Balber AE et al. Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol 2003; 122: 99108.
  • 7
    Hess DA, Meyerrose TE, Wirthlin L et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004; 104: 16481655.
  • 8
    Corti S, Locatelli F, Papadimitriou D et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet 2006; 15: 167187.
  • 9
    Mitchell JB, McIntosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006; 24: 376385.
  • 10
    Gentry T, Foster S, Winstead L et al. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy 2007; 9: 259274.
  • 11
    Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895902.
  • 12
    Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555567.
  • 13
    Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 2008; 26: 28132820.
  • 14
    Huang EH, Hynes MJ, Zhang T et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 18.
  • 15
    Yu C, Yao Z, Dai J, et al. Aldehyde dehydrogenase is a marker of prostate cancer stem cell-like cells in cell lines [abstract 1300]. Presented at: 98th American Association for Cancer Research Annual Meeting; April 14–18, 2007; Los Angeles, CA.
  • 16
    Dalerba P, Dylla SJ, Park IK et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007; 104: 1015810163.
  • 17
    Seigel GM, Campbell LM, Narayan M et al. Cancer stem cell characteristics in retinoblastoma. Mol Vis 2005; 11: 729737.
  • 18
    Tsujimura A, Koikawa Y, Salm S et al. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 2002; 157: 12571265.
  • 19
    Burger PE, Xiong X, Coetzee S et al. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A 2005; 102: 71807185.
  • 20
    Cunha GR, Donjacour A. Mesenchymal-epithelial interactions: technical considerations. Prog Clin Biol Res 1987; 239: 273282.
  • 21
    Norman JT, Cunha GR, Sugimura Y. The induction of new ductal growth in adult prostatic epithelium in response to an embryonic prostatic inductor. Prostate 1986; 8: 209220.
  • 22
    Xin L, Ide H, Kim Y et al. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci U S A 2003; 100: 1189611903.
  • 23
    Salm SN, Takao T, Tsujimura A et al. Differentiation and stromal-induced growth promotion of murine prostatic tumors. Prostate 2002; 51: 175188.
  • 24
    Winter MJ, Nagtegaal ID, van Krieken JH et al. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 2003; 163: 21392148.
  • 25
    Wang Y, Hayward S, Cao M et al. Cell differentiation lineage in the prostate. Differentiation 2001; 68: 270279.
  • 26
    Xin L, Lawson DA, Witte ON. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A 2005; 102: 69426947.
  • 27
    Holmes C, Stanford WL. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 2007; 25: 13391347.
  • 28
    Oka M, Tagoku K, Russell TL et al. CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell 2002; 13: 12741281.
  • 29
    Kanatsu-Shinohara M, Toyokuni S, Shinohara T. CD9 is a surface marker on mouse and rat male germline stem cells. Biol Reprod 2004; 70: 7075.
  • 30
    Klassen H, Schwartz MR, Bailey AH et al. Surface markers expressed by multipotent human and mouse neural progenitor cells include tetraspanins and non-protein epitopes. Neurosci Lett 2001; 312: 180182.
  • 31
    Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 13221326.
  • 32
    Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med 2000; 191: 253264.
  • 33
    Potten CS, Wilson JW, Booth C. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 1997; 15: 8293.
  • 34
    Salm SN, Burger PE, Coetzee S et al. TGF-beta maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol 2005; 170: 8190.
  • 35
    Tiberio R, Marconi A, Fila C et al. Keratinocytes enriched for stem cells are protected from anoikis via an integrin signaling pathway in a Bcl-2 dependent manner. FEBS Lett 2002; 524: 139144.
  • 36
    Kloepper JE, Tiede S, Brinckmann J et al. Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp Dermatol 2008; 17: 592609.
  • 37
    Ohyama M, Terunuma A, Tock CL et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006; 116: 249260.
  • 38
    Kawasaki BT, Mistree T, Hurt EM et al. Coexpression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. Biochem Biophys Res Commun 2007; 364: 778782.
  • 39
    Kim M, Turnquist H, Jackson J et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002; 8: 2228.
  • 40
    Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002; 99: 507512.
  • 41
    Tai MH, Chang CC, Kiupel M et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005; 26: 495502.
  • 42
    Zhou S, Schuetz JD, Bunting KD et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 10281034.
  • 43
    Shackleton M, Vaillant F, Simpson KJ et al. Generation of a functional mammary gland from a single stem cell. Nature 2006; 439: 8488.
  • 44
    Yin AH, Miraglia S, Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 50025012.
  • 45
    Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000; 97: 1472014725.
  • 46
    Leong KG, Wang BE, Johnson L et al. Generation of a prostate from a single adult stem cell. Nature 2008; 456: 804808.
  • 47
    Richardson GD, Robson CN, Lang SH et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004; 117: 35393545.
  • 48
    Kasper S. Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev 2008; 4: 193201.
  • 49
    Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585595.
  • 50
    Goto K, Salm SN, Coetzee S et al. Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis. Stem Cells 2006; 24: 18591868.
  • 51
    O'Brien CA, Pollett A, Gallinger S et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106110.
  • 52
    Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111115.
  • 53
    Grey BR, Oates JE, Brown MD et al. Cd133: a marker of transit amplification rather than stem cell phenotype in the prostate? BJU Int 2009; 103: 856858.
  • 54
    Shmelkov SV, Butler JM, Hooper AT et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118: 21112120.
  • 55
    Moreb JS. Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 2008; 3: 237246.
  • 56
    Wilson JG, Warkany J. Malformations in the genitourinary tract induced by maternal vitamin A deficiency in the rat. Am J Anat 1948; 83: 357407.
  • 57
    Vezina CM, Allgeier SH, Fritz WA et al. Retinoic acid induces prostatic bud formation. Dev Dyn 2008; 237: 13211333.
  • 58
    Aboseif SR, Dahiya R, Narayan P et al. Effect of retinoic acid on prostatic development. Prostate 1997; 31: 161167.
  • 59
    Lohnes D, Kastner P, Dierich A et al. Function of retinoic acid receptor gamma in the mouse. Cell 1993; 73: 643658.
  • 60
    Pasquali D, Thaller C, Eichele G. Abnormal level of retinoic acid in prostate cancer tissues. J Clin Endocrinol Metab 1996; 81: 21862191.
  • 61
    Okuducu AF, Janzen V, Ko Y et al. Cellular retinoic acid-binding protein 2 is down-regulated in prostate cancer. Int J Oncol 2005; 27: 12731282.
  • 62
    Huang J, Powell WC, Khodavirdi AC et al. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 2002; 62: 48124819.
  • 63
    Kim H, Lapointe J, Kaygusuz G et al. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 2005; 65: 81188124.
  • 64
    Richter F, Joyce A, Fromowitz F et al. Immunohistochemical localization of the retinoic Acid receptors in human prostate. J Androl 2002; 23: 830838.
  • 65
    Quash G, Fournet G, Courvoisier C et al. Aldehyde dehydrogenase inhibitors: alpha,beta-acetylenic N-substituted aminothiolesters are reversible growth inhibitors of normal epithelial but irreversible apoptogens for cancer epithelial cells from human prostate in culture. Eur J Med Chem 2008; 43: 906916.
  • 66
    Njar VC, Gediya L, Purushottamachar P et al. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem 2006; 14: 43234340.
  • 67
    Chute JP, Muramoto GG, Whitesides J et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A 2006; 103: 1170711712.
  • 68
    Purton LE, Dworkin S, Olsen GH et al. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med 2006; 203: 12831293.
  • 69
    Everts HB, King LE,Jr., Sundberg JP et al. Hair cycle-specific immunolocalization of retinoic acid synthesizing enzymes Aldh1a2 and Aldh1a3 indicate complex regulation. J Invest Dermatol 2004; 123: 258263.